Rising antimicrobial resistance (AMR) threatens the effectiveness of essential medical treatments and calls for innovative solutions that help reduce unnecessary exposure to antibiotics in humans, animals, and the environment.
AMR-Global brings together public and private parties to tackle this challenge by developing new knowledge, technologies, and applications. To further shape its mission, the AMR-Global Steering Group is currently preparing a program proposal for Health~Holland’s Public-Private Partnership (PPP) Programme 2027.
With this proposal, we aim to develop a programme in which public and private partners jointly address innovation challenges, explore opportunities, and lay the foundation for new PPP projects that fall under these themes:
biomolecular & cell technologies,
imaging & precision diagnostics,
AI in healthcare & labour-saving.
We have already completed the initial stages of the application process. The next step is to submit the full program application by 2 October 2026 (17:00 CEST).
To do so, we would like to engage with private-sector parties to:
Identify innovation challenges and opportunities within the identified themes,
Explore the knowledge, technologies, and applications needed to achieve impact,
Jointly shape the programme proposal,
Prepare for future public-private collaborations and PPP projects.
Interested? Please contact AMR-Global project manager Mark van Knegsel.